All news

© GettyImages/metamorworks

Fujifilm expands its gene therapy drug CDMO business

By Jane Byrne

Fujifilm is boosting its gene therapy offering, taking the first steps to expand its viral vector contract development and manufacturing organization (CDMO) services to Europe, at the site of Fujifilm Diosynth Biotechnologies (FDB) in the North East of...

Vaxxas’ needle-free vaccine tech gets boost from US Government

Vaxxas’ needle-free vaccine tech gets boost from US Government

By Rachel Arthur

Vaxxas has received a $22m US Government award to conduct a Phase 1 clinical study for its novel skin-patch vaccination platform. While the trial will use a pandemic influenza vaccine, Vaxxas is also investigating opportunities to use the technology against...

© GettyImages/solarseven

Cobra to supply plasmids to UK COVID-19 vaccine developer

By Jane Byrne

Contract development and manufacturing organization (CDMO), Cobra Biologics, has been selected to manufacture plasmids for a Phase I clinical trial of a COVID-19 vaccine being developed by UK company, Scancell.

Pic:getty/dilenua

Sartorius acquires BIA Separations for $423m

By Rachel Arthur

German life science company Sartorius will merge Slovenian purification specialist BIA Separations with Sartorius Stedim Biotech, in a deal worth €360m ($423m).

(Ca-ssis/iStock via Getty Images Plus)

CPhI Festival of Pharma

Vetter to profile cleanroom concept at CPhI

By Jenni Spinner

The aseptic technology specialist plans to discuss its V-CRT cleanroom technology at the upcoming CPhI Festival of Pharma online event in October.

(robeo/iStock via Getty Images Plus)

CPhI Festival of Pharma

Noble to address drug delivery evolution at CPhI

By Jenni Spinner

A leader from the pharma solutions firm will discuss the future of drug delivery at a keynote during the CPhI Festival of Pharma virtual event.

(gorodenkoff/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI: SPI Pharma talks supply chain challenges

By Jenni Spinner

The pharma ingredients provider discusses new products, supply-chain obstacles, and what the future of the industry might hold, ahead of the online event.

Follow us

Products

View more

Webinars